Noncytotoxic Vesicant Medications and Solutions
INS established a vesicant task force with the goal of developing an evidence-based list of noncytotoxic vesicant medications/solutions.
Outside of oncology practice, there is not a list of noncytotoxic vesicants as established by a professional organization. INS identified the need to address this gap based on the following premise:the first step in preventing extravasation is the identification and recognition of vesicant drugs and solutions.
The scope of work was limited to creating an evidence-based list of noncytotoxic vesicant medications/solutions and developing an extravasation checklist that outlines risk reduction strategies including early recognition of signs and symptoms of extravasation.